Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Charlesworth Group (USA)

Charlesworth Press is located in Wakefield, West Yorkshire, UK. Printing operations are situated alongside our bindery division, Hammonds for maximum efficiency. Continuous investment means the Charlesworth’s services continue to develop in order to serve the changing needs of our clients. Our press room and bindery remain equipped with the latest machinery to deliver rapid turnaround yet still provide the best possible quality services at competitive prices.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications Logo

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Advertising, Branding, Conference/meetings/events, Creative and design, Digital communications, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Sales, Training

- PMLiVE

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Sales

Company Details

The Charlesworth Group (USA)
3624 Market St 5E, Philadelphia, Pennsylvania, 19104, United States
(00) +1 2159221611
Contact The Charlesworth Group (USA)
Website

 Latest Content from PMHub 

The Eleven guide to NFTs

Press Releases | March 24, 2022 | 11 London

Non-Fungible Tokens (NFTs) have been making waves in the news lately, specifically around the millions of dollars being exchanged for unique digital art assets. Investors have been queuing up to...

Extraordinary lives: advancing change in rare diseases (Part 2)

Press Releases | March 24, 2022 | Lucid Group Communications Limited

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 2)

Videos and Podcasts | March 24, 2022 | Lucid Group Communications Limited

In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

The power of influence in transforming women’s health

White Papers and Resources | March 24, 2022 | Say Communications

Over the past four years HRT prescriptions have doubled in the UK, the cause was turbo charged by the action of celebrities and influencers.

KVA launch the KVA Mediverse, leading the way in VR healthcare comms

Press Releases | March 23, 2022 | KVA

KVA announce their new unique VR offering

Nucleus Global launches Nucleus X Consulting, a specialist consultancy with deep expertise in patient engagement, rare disease, and early-phase medical commercialization

Press Releases | March 22, 2022 | Nucleus Global

Nucleus Global, the largest specialist medical communications network in the world, announces the launch of a new consultancy to add to its family of agencies. Nucleus X Consulting consists of...

Top 10 Most Common Participant Comments – Online Advisory Boards

White Papers and Resources | March 21, 2022 | Impetus Digital

What advisors and participants have to say about the Impetus InSite Platform!

Healthcare services entrepreneur David Rowley joins KVA

Press Releases | March 21, 2022 | KVA

KVA appoints David Rowley to act as advisor to the board

Engaging doctors around the globe

White Papers and Resources | March 21, 2022 | M3 (EU)

Embedding a digital strategy as a prominent part of a pharmaceutical marketing campaign is becoming ever more important. Despite some perceived reluctance on the part of the industry, pharmaceutical companies...

David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access

Press Releases | March 21, 2022 | OPEN Health

David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access